Julio
Dávila Valls
Investigador no período 2015-2017
Hospital Infanta Leonor
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Infanta Leonor (7)
2024
-
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis
American Journal of Hematology
-
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
eClinicalMedicine, Vol. 71
-
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry
Haematologica
2023
2022
-
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Blood, Vol. 140, Núm. 26, pp. 2773-2787
-
TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features
American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914
2020
-
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
International Journal of Cancer, Vol. 147, Núm. 10, pp. 2780-2792